**Core Concept**
Mycosis fungoides is a cutaneous T-cell lymphoma characterized by chronic, progressive skin involvement, with a variable clinical course. It is the most common primary cutaneous lymphoma, often presenting with erythematous patches, plaques, and later tumors.

**Why the Correct Answer is Right**
Mycosis fungoides is indeed an indolent lymphoma with a slow progression, but it has a **poor long-term prognosis**, especially in advanced stages. While early cases may appear benign, progression to systemic disease, lymph node involvement, or transformation to aggressive lymphoma occurs in a significant proportion of patients. The disease is often misdiagnosed initially due to its non-specific presentation, and survival rates are lower than expected—especially in elderly or immunocompromised patients. Hence, the statement that it has a "good prognosis" is **not true**.

**Why Each Wrong Option is Incorrect**
Option A: Pautrier microabscesses are indeed a hallmark of mycosis fungoides, seen in early skin lesions due to T-cell infiltration.
Option B: Diffuse erythroderma is a common presentation in advanced or disseminated disease, particularly in the later stages.
Option D: Erythroderma (widespread redness) is a key feature, especially in the chronic or progressive phases of the disease.

**Clinical Pearl / High-Yield Fact**
Mycosis fungoides is often mistaken for eczema or psoriasis due to its early skin manifestations. Early diagnosis is critical, and biopsy with immunohistochemistry (e.g., CD3, CD45RO) is essential. Despite being indolent, it is **not** a disease with a good prognosis—especially with advanced disease.

✓ Correct Answer: C. It has a indolent course and good prognosis